Jin Y, Zhang Y, Wang M, Bai X, et al. Adverse events associated with Lutetium-177-PSMA-617 (Pluvicto((R))) in advanced prostate cancer: a disproportionality analysis based on the fda's adverse event reporting system (FAERS). BMC Cancer 2025;25:1470.
PMID: 41029272